DelveInsight's 'Severe Asthma Pipeline Insight 2024' report provides comprehensive global coverage of pipeline severe asthma ...

Over 40 companies are working on more than 50 therapies for severe asthma. The severe asthma market is growing due to a ...

AstraZeneca Plc (NASDAQ:AZN) and Amgen Inc (NASDAQ:AMGN) released topline data from the Phase 3 WAYPOINT trial of Tezspire ...

Upstream Bio garners analyst optimism for its lead drug verekitug, which could disrupt the $7.5 billion asthma biologics ...

The study that Community Health Center patients, like Cridele, have been participating in seeks to alleviate the strain on rural patients by testing their lung performance at home, with a mobile ...

Tessa Romero, an analyst from J.P. Morgan, has initiated a new Buy rating on Upstream Bio, Inc. (UPB). Tessa Romero’s rating is based on ...

Advancing Phase 2 clinical trials of verekitug in patients with severe asthma and CRSwNP –– Commenced startup for a Phase 2 clinical trial in ...

but the new formulation will allow patients to take greater control of their treatment. Like its predecessor, it is approved in the EU for use in patients 12 years and older with severe asthma who ...

One of the reasons that Black children have higher rates of asthma is their comorbid conditions. For instance, obesity is ...

leading to more frequent and severe asthma attacks and an increased risk of pneumonia, respiratory failure, and even death. Although asthma may never be completely cured, keeping it well-controlled ...

The first-in class medicine for severe asthma co-developed ... of asthma exacerbations and uncontrolled asthma receiving currently approved inhaled treatment versus placebo. The trial showed ...

has been studied in severe asthmatics and in COPD patients with a history of asthma, showing an additional bronchodilator effect on top of the current asthma treatment. The first large study on ...